UM

Browse/Search Results:  1-8 of 8 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
In vitro assays suggest Shenqi Fuzheng Injection has the potential to alter melanoma immune microenvironment Journal article
Journal of Ethnopharmacology, 2016,Volume: 194,Page: 15-19
Authors:  Du J.;  Cheng B.C.Y.;  Fu X.-Q.;  Su T.;  Li T.;  Guo H.;  Li S.-M.;  Wu J.-F.;  Yu H.;  Huang W.-H.;  Cao H.;  Yu Z.-L.
Favorite  |  View/Download:2/0  |  Submit date:2019/01/17
Ononin (PubChem CID: 442813)  
Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials Journal article
Acta Psychiatrica Scandinavica, 2016,Volume: 134,Issue: 5,Page: 385-398
Authors:  Zheng W.;  Xiang Y.-T.;  Xiang Y.-Q.;  Li X.-B.;  Ungvari G.S.;  Chiu H.F.K.;  Correll C.U.
Favorite  |  View/Download:3/0  |  Submit date:2018/12/18
Antipsychotic  Meta-analysis  Metabolic Abnormalities  Topiramate  Weight Gain  
Wuling capsule for major depressive disorder: A meta-analysis of randomised controlled trials Journal article
East Asian Archives of Psychiatry, 2016,Volume: 26,Issue: 3,Page: 87-97
Authors:  Zheng W.;  Zhang Y.F.;  Zhong H.Q.;  Mai S.M.;  Yang X.H.;  Xiang Y.T.
Favorite  |  View/Download:5/0  |  Submit date:2018/12/18
Antidepressive agents  Depressive disorder major  Drugs Chinese herbal  
Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis Journal article
Human Psychopharmacology, 2016,Page: 286-295
Authors:  Zheng W.;  Xiang Y.-Q.;  Li X.-B.;  Ungvari G.S.;  Chiu H.F.K.;  Sun F.;  D'Arcy C.;  Meng X.;  Xiang Y.-T.
Favorite  |  View/Download:2/0  |  Submit date:2018/12/18
Antipsychotic  Cognitive Function  Huperzine a  Meta-analysis  Schizophrenic-spectrum Disorders  Systematic Review  
Electroconvulsive therapy added to non-clozapine antipsychotic medication for treatment resistant schizophrenia: Meta-analysis of randomized controlled trials Journal article
PLoS ONE, 2016,Volume: 11,Issue: 6
Authors:  Zheng W.;  Cao X.-L.;  Ungvari G.S.;  Xiang Y.-Q.;  Guo T.;  Liu Z.-R.;  Wang Y.-Y.;  Forester B.P.;  Seiner S.J.;  Xiang Y.-T.
Favorite  |  View/Download:2/0  |  Submit date:2018/12/18
Extract of Ginkgo biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials Journal article
Pharmacopsychiatry, 2016,Volume: 49,Issue: 3,Page: 107-111
Authors:  Zheng W.;  Xiang Y.-Q.;  Ng C.H.;  Ungvari G.S.;  Chiu H.F.K.;  Xiang Y.-T.
Favorite  |  View/Download:3/0  |  Submit date:2018/12/18
Antipsychotic  Ginkgo Biloba  Meta-analysis  Tardive Dyskinesia  
Huperzine A for treatment of cognitive impairment in major depressive disorder: a systematic review of randomized controlled trials Journal article
Shanghai Archives of Psychiatry, 2016,Volume: 28,Issue: 2,Page: 64-71
Authors:  Zheng W.;  Xiang Y.-Q.;  Ungvari G.S.;  Chiu H.F.;  Ng C.H.;  Wang Y.;  Xiang Y.-T.
Favorite  |  View/Download:5/0  |  Submit date:2018/12/18
Adjunctive treatment  Cognitive function  Depression  Huperzine A  Meta-analysis  
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials Journal article
EXPERT OPINION ON DRUG SAFETY, 2016,Volume: 15,Issue: 5,Page: 591-612
Authors:  Galling, B;  Roldan, A;  Rietschel, L;  Hagi, K;  Walyzada, F;  Zheng, W;  Cao, XL;  Xiang, YT;  Kane, JM;  Correll, CU
Favorite  |  View/Download:3/0  |  Submit date:2019/01/07
Monotherapy  Metaanalysis  Antipsychotics  Augmentation  Combination  Polypharmacy  Cotreatment  Adverse Effects  Tolerability  Safety  Schizophrenia